ImmunologybioRxivPreprint
TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content
DOI 10.1101/2023.08.16.553509
Author
E. Szegezdi
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2022-2023 · peak 2/yrCo-Author Collaboration Network
10 top collaborators · 21 mutual co-author linksFocal author (center)Selected co-authorORCID co-authorUnlinked name
Curved chords = mutual co-authorship3 papers
Recent·Most cited
- Cancer BiologybioRxiv
Natural killer cell-mimic nanoparticles can actively target and kill acute myeloid leukemia cells
H. Alizadeh Zeinabad, W. J. Yeoh, M. Lomora…·E. Szegezdi
This study develops NK cell-mimic nanoparticles that target and kill AML cells by combining TRAIL cytotoxicity and CD16-based antibody recognition.
DOI 10.1016/j.biomaterials.2023.122126 - Cancer BiologybioRxivPreprint
Single-cell characterisation of the hematopoietic bone marrow interactome in health and disease
S. Ennis, A. Conforte, E. O'Reilly…·E. Szegezdi
The paper characterizes the hematopoietic bone marrow interactome in health and acute myeloid leukemia using single-cell gene expression data, revealing dysregulated ligand-receptor interactions and the role of TGFB1 in AML progression.